Axsome Therapeutics, Inc. (AXSM) Ownership

$85.13

south_east
-$1.32 (-1.53%)
Day's range
$84.13
Day's range
$87.09

Axsome Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RTW INVESTMENTS, LP 02/14/2025 4.05 M $342.79 M   -3.30% 8.42%
VANGUARD GROUP INC 02/11/2025 3.90 M $330.19 M   -2.32% 8.11%
BLACKROCK FUNDING, INC. /DE 02/07/2025 3.53 M $298.96 M   3.97% 7.34%
FAIRMOUNT FUNDS MANAGEMENT LLC 02/14/2025 1.47 M $124.29 M   -37.76% 3.05%
BVF INC/IL 02/14/2025 1.39 M $117.44 M   32.70% 2.88%
FMR LLC 02/13/2025 1.00 M $84.65 M   -8.05% 2.08%
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 1.00 M $84.61 M   0.00% 2.08%
MACQUARIE GROUP LTD 02/14/2025 964,047 $81.57 M   -3.14% 2.00%
STATE STREET CORP 02/14/2025 947,251 $80.15 M   3.32% 1.97%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 912,538 $77.23 M   0.45% 1.90%
EVENTIDE ASSET MANAGEMENT, LLC 02/14/2025 828,711 $70.12 M   0.10% 1.72%
ALETHEA CAPITAL MANAGEMENT, LLC 02/14/2025 734,317 $62.13 M   -0.57% 1.53%
INVESCO LTD. 02/13/2025 692,464 $58.59 M   10.76% 1.44%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 673,157 $56.96 M   -9.37% 1.40%
PERCEPTIVE ADVISORS LLC 02/14/2025 664,074 $56.19 M   -15.17% 1.38%
HOOD RIVER CAPITAL MANAGEMENT LLC 02/14/2025 644,785 $54.56 M   3.15% 1.34%
LAZARD ASSET MANAGEMENT LLC 02/14/2025 537,669 $45.49 M   525.69% 1.12%
SOFINNOVA INVESTMENTS, INC. 02/14/2025 491,726 $41.60 M   29.56% 1.02%
02/14/2025 470,000 $39.77 M   100.00% 0.98%
PFM HEALTH SCIENCES, LP 02/14/2025 467,427 $39.55 M   0.00% 0.97%
WOODLINE PARTNERS LP 02/14/2025 408,441 $34.56 M   36.80% 0.85%
NORGES BANK 02/12/2025 403,026 $34.10 M   100.00% 0.84%
JANE STREET GROUP, LLC 02/14/2025 395,400 $33.45 M   245.33% 0.82%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 391,000 $33.08 M   22.11% 0.81%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 347,900 $29.44 M   38.77% 0.72%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 328,034 $27.75 M   1.69% 0.68%
CORMORANT ASSET MANAGEMENT, LP 02/14/2025 325,000 $27.50 M   -18.75% 0.68%
LOOMIS SAYLES & CO L P 02/12/2025 290,111 $24.55 M   -2.84% 0.60%
TRI LOCUM PARTNERS LP 02/14/2025 249,769 $21.13 M   172.31% 0.52%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 221,202 $18.72 M   118.10% 0.46%
CAPTION MANAGEMENT, LLC 02/14/2025 220,000 $18.61 M   100.00% 0.46%
GOLDMAN SACHS GROUP INC 02/11/2025 217,567 $18.41 M   -40.00% 0.45%
PRINCIPAL FINANCIAL GROUP INC 01/31/2025 207,065 $17.52 M   6,002.71% 0.43%
JPMORGAN CHASE & CO 02/12/2025 201,902 $17.08 M   -4.81% 0.42%
FIRST TURN MANAGEMENT, LLC 02/14/2025 192,146 $16.26 M   -24.74% 0.40%
AVIDITY PARTNERS MANAGEMENT LP 02/14/2025 188,000 $15.91 M   -36.51% 0.39%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 185,661 $15.71 M   1,251.93% 0.39%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 185,138 $15.66 M   -65.88% 0.38%
FRANKLIN RESOURCES INC 02/12/2025 182,290 $15.42 M   13.55% 0.38%
BALYASNY ASSET MANAGEMENT L.P. 02/14/2025 181,213 $15.33 M   191.49% 0.38%
CHECKPOINT CAPITAL L.P. 02/14/2025 174,769 $14.79 M   -16.63% 0.36%
RAYMOND JAMES FINANCIAL INC 02/13/2025 174,586 $14.77 M   100.00% 0.36%
MAN GROUP PLC 02/14/2025 163,388 $13.82 M   100.00% 0.34%
JANE STREET GROUP, LLC 02/14/2025 160,400 $13.57 M   48.11% 0.33%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 155,911 $13.19 M   413.37% 0.32%
UBS GROUP AG 02/14/2025 147,347 $12.47 M   208.50% 0.31%
HSBC HOLDINGS PLC 02/14/2025 136,785 $11.57 M   -0.20% 0.28%
BANK OF NEW YORK MELLON CORP 02/04/2025 134,550 $11.38 M   -1.39% 0.28%
US BANCORP \DE\ 02/05/2025 131,019 $11.09 M   -1.58% 0.27%
CAPTION MANAGEMENT, LLC 02/14/2025 128,900 $10.91 M   268.29% 0.27%

Axsome Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 371 institutional investors and hedge funds held shares of Axsome Therapeutics, Inc.. The most heavily invested institutionals were:

RTW INVESTMENTS, LP: 4.05 M

VANGUARD GROUP INC: 3.9 M

BlackRock Funding, Inc. /DE: 3.53 M

Fairmount Funds Management LLC: 1.47 M

BVF INC/IL: 1.39 M

FMR LLC: 1 M

77.27% of Axsome Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 45.20 M shares in the last 24 months. This purchase volume represents approximately $3.85 B in transactions.